ZNF219 Knockout U2OS Cell Line
Cat.No.:
EDC07764
Species:
Human
Cell Name:
U2OS
Gene:
ZNF219
Gene ID:
51222
Size:
1×10⁶cells
ZNF219 Knockout U2OS Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07764 |
|---|---|
| Product Name | ZNF219 Knockout U2OS Cell Line |
| Species | Human |
| Cell Line | U2OS |
| Cellosaurus ID | CVCL_0042 |
| Cell Line Synonyms | U-2 OS, U-2OS, U-2-OS, U2-OS, U20-S, U20S, 2T |
| Gene ID | |
| Gene | ZNF219 |
| Summary |
This gene is a member of the Kruppel-like zinc finger gene family. The encoded protein functions as a transcriptional repressor of the high mobility group nucleosome binding domain 1 protein, which is associated with transcriptionally active chromatin. [provided by RefSeq, Apr 2017]
|
| Associated Diseases | Osteosarcoma |
| Digestion Time | ~2 min |
| Morphology | Adherent |
| Passage Ratio | 1:3 |
| Complete Culture Medium | mcCoy5A+10% FBS |
| Freezing Medium | 95% complete culture medium + 5% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: U2OS | STR Info (Cell bank) Cell Line: U2OS | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1PO | 13 | 13 | ||
| D1S1656 | 15 | 17.3 | 16 | 17.3 |
| D2S1338 | 20 | 24 | 20 | 24 |
| D3S1358 | 16 | 16 | ||
| D5S818 | 11 | 11 | ||
| D6S1043 | 11 | 11 | ||
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D12S391 | 19 | 20 | 19 | 20 |
| D13S317 | 13 | 13 | ||
| D16S539 | 11 | 12 | 11 | 12 |
| D18S51 | 14 | 14 | ||
| D19S433 | 15 | 15 | ||
| D21S11 | 31 | 31 | ||
| FGA | 20 | 20 | ||
| Penta D | 9 | 9 | ||
| Penta E | 10 | 13 | 10 | 13 |
| TH01 | 6 | 9.3 | 6 | 9.3 |
| TPOX | 11 | 12 | 11 | 12 |
| VWA | 14 | 18 | 14 | 18 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying ZNF219 function, ZNF219 Knockout U2OS Cell Line or ZNF219 overexpression U2OS Cell Line?
The choice depends on the experimental question. The Knockout line is appropriate for asking whether ZNF219 is required for transcriptional regulation at candidate targets or for specific gene expression programs. Overexpression is appropriate when asking whether forced ZNF219 expression is sufficient to activate or repress target loci, or when probing dose-dependent regulatory effects.
For a transcription factor where the activation/repression mode is still being defined, the EDITGENE Knockout line provides the more interpretable starting point: it reveals which transcripts depend on endogenous ZNF219 without confounding effects from non-physiological expression levels. Pairing with rescue experiments — including domain-mutant constructs — is the most rigorous way to assign mechanism to specific protein features.
What are the application scenarios for this model?
Primary applications:
• Chromatin occupancy studies: ChIP-qPCR or ChIP-seq to investigate potential ZNF219 binding sites — this knockout line serves as a critical negative control for signal specificity.
• Transcriptomic analysis: RNA-seq to identify transcriptional changes associated with ZNF219 loss and generate candidate downstream program hypotheses; direct target assignment requires orthogonal validation (reporter assays, CUT&RUN).
• Reporter assays: luciferase-based validation of regulatory activity at specific genomic elements of interest.
• Epigenomic screening: integration into functional genomics workflows examining transcription factor-associated chromatin regulation.
EDITGENE recommends this model for researchers focused on zinc finger transcription factor biology and chromatin-associated gene regulation.
Is this ZNF219 Knockout U2OS Cell Line compatible with overexpression rescue experiments?
Yes. As a transcription factor, rescue experiments for ZNF219 require attention to nuclear localization and expression level:
• Construct design: use a codon-modified ZNF219 coding sequence with a C-terminal tag (FLAG, HA). N-terminal tags should be avoided if they overlap with nuclear localization signals.
• Nuclear localization control: confirm by immunofluorescence that exogenous ZNF219 localizes to the nucleus. Cytoplasmic mislocalization (often from tag interference or truncated constructs) will not rescue transcriptional regulatory phenotypes.
• Expression level: ZNF219, like many transcription factors, can exhibit dose-dependent effects. Titrate using inducible systems (Tet-On) to approximate endogenous levels — overexpression artifacts can produce phenotypes opposite to those of loss-of-function.
• Domain mutants: rescue with zinc finger DNA-binding mutants provides a critical control for assigning observed effects to ZNF219's transcriptional activity rather than non-DNA-binding functions.
U2OS exhibits high transfection efficiency and stable lentiviral integration, with flat morphology that supports imaging-based localization validation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download